Merck & Co. Inc. buy BMO Capital Markets
Start price
01.11.24
/
50%
€94.50
Target price
01.11.25
€125.35
Performance (%)
-20.95%
End price
02.11.25
€74.70
Summary
This prediction ended on 02.11.25 with a price of €74.70. The price of Merck & Co. Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.95%. A total of €1.58 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 1.198% | 1.198% | -11.518% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at BMO Capital Markets from $150.00 to $136.00. They now have an "outperform" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Stopped prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€101.00
27.10.23
27.10.23
€125.02
27.10.24
27.10.24
-4.06%
28.10.24
28.10.24
